Antidepressant-Like Activity of Agomelatine in the Mouse Unpredictable Chronic Mild Stress Model

Authors

  • Oguz Mutlu,

  • Esen Gumuslu,

  • Guner Ulak,

  • Ipek Komsuoglu Celikyurt,

  • Furuzan Akar,

  • Emine Bektas,

  • Tugce Demirtas,

  • Hale Maral Kır,

  • Mahmut Mert Musul,

  • Faruk Erden

Errata

This article corrects:

  1. Antidepressant-Like Activity of Agomelatine in the Mouse Unpredictable Chronic Mild Stress Model Volume 74, Issue 3, 203–215, Article first published online: 22 February 2013

Correspondence to: Oguz Mutlu, Department of Pharmacology, Faculty of Medicine, Kocaeli University, 41380 Kocaeli, Turkey.

E-mail: oguzmutlu80@hotmail.com

In the recently published article [Drug Dev Res volume 74, number 3, 2013 on pages 203-215 (ddr.21064)], there was a mistake in the name, place and country of the manufacturer of agomelatine. In the subsection “Experimental groups and drug administration”, it was written “… the animals were treated with agomelatine (10 mg/kg, dissolved in 10% DMSO) (Servier Pharmaceuticals, Orleans, France)”.

This statement is now corrected to read: “… as the animals were treated with agomelatine (10 mg/kg, dissolved in 10% DMSO) (Wuhan Sunrise Technology Development Company Limited, Wuhan, China).

Ancillary